Zobrazeno 1 - 10
of 16
pro vyhledávání: '"WangRui"'
Autor:
Shuchang Wang, Weifeng Zhang, Xinrui Wu, Zhu Zhu, Yuanbiao Chen, Wangrui Liu, Junnfei Xu, Li Chen, Chun Zhuang
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-17 (2024)
Abstract Background Gastric cancer (GC) is one of the most prevalent malignant tumors worldwide and is associated with high morbidity and mortality rates. However, the specific biomarkers used to predict the postoperative prognosis of patients with g
Externí odkaz:
https://doaj.org/article/378f75a2eb8d40ae868b733052090b53
Autor:
Aihetaimujiang Anwaier, Wenhao Xu, Wangrui Liu, Shiyin Wei, Xi Tian, Yuanyuan Qu, Jianfeng Yang, Hailiang Zhang, Dingwei Ye
Publikováno v:
Journal of the National Cancer Center, Vol 3, Iss 3, Pp 236-249 (2023)
Background: The tumor microenvironment (TME) performs a crucial function in the tumorigenesis and response to immunotherapies of clear cell renal cell carcinoma (ccRCC). However, a lack of recognized pre-clinical TME-based risk models poses a great c
Externí odkaz:
https://doaj.org/article/969129b739b1425c96d291d4984cd366
Autor:
Wenhao Xu, Aihetaimujiang Anwaier, Wangrui Liu, Xi Tian, Jiaqi Su, Guohai Shi, Yuanyuan Qu, Hailiang Zhang, Dingwei Ye
Publikováno v:
Journal of the National Cancer Center, Vol 2, Iss 3, Pp 162-170 (2022)
Background: The genomic background affects the occurrence and metastasis of cancers, including clear cell renal cell carcinoma (ccRCC). However, reports focusing on the prognostic mutational signature of Chinese ccRCC are lacking. Methods: Overall, 9
Externí odkaz:
https://doaj.org/article/4551aafee0e74d6badd687ba53692d3b
Autor:
Xinrui Wu, Chuanyu Li, Zhisu Wang, Yundi Zhang, Shifan Liu, Siqi Chen, Shuai Chen, Wangrui Liu, Xiaoman Liu
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-17 (2022)
Abstract Background Glioblastoma is one of the most common brain cancers in adults, and is characterized by recurrence and little curative effect. An effective treatment for glioblastoma patients remains elusive worldwide. 7-methylguanosine (m7G) is
Externí odkaz:
https://doaj.org/article/6056de8f1da740eb9bb22335ac7be76e
Autor:
Wenhao Xu, Wangrui Liu, Aihetaimujiang Anwaier, Xi Tian, Jiaqi Su, Guohai Shi, Shiyin Wei, Yuanyuan Qu, Hailiang Zhang, Dingwei Ye
Publikováno v:
Discover Oncology, Vol 13, Iss 1, Pp 1-16 (2022)
Abstract Clear cell renal cell carcinoma (ccRCC) is one of the most common malignant genitourinary cancers with high recurrence risk worldwide. Recently, multi-omics data facilitate obtaining a molecular landscape of tumor development, and were imple
Externí odkaz:
https://doaj.org/article/3a36f0589ac14f33ae63c49bfd4d3fa9
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Immunotherapy is widely regarded as a promising treatment for cancer. However, the immune effector phase suppression of tumor microenvironment (TME) and the generation of immune-related adverse events limit its application. Research indicates that so
Externí odkaz:
https://doaj.org/article/f82f1613050b4d21b465521979d55294
Autor:
Kun Chang, Jiaqi Su, Chuanyu Li, Aihetaimujiang Anwaier, Wangrui Liu, Wenhao Xu, Yuanyuan Qu, Hailiang Zhang, Dingwei Ye
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundIncreasing evidence indicates that L-dopa decarboxylase (DDC), which mediates aberrant amino acid metabolism, is significantly associated with tumor progression. However, the impacts of DDC are not elucidated clearly in clear cell renal cel
Externí odkaz:
https://doaj.org/article/78845e10ce2143dd85e8a877e61e6d83
Autor:
Wangrui Liu, Jianfeng Xiang, Xinrui Wu, Shiyin Wei, Haineng Huang, Yu Xiao, Bo Zhai, Tao Wang
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Prostate adenocarcinoma (PRAD) is an extremely common type of cancer in the urinary system. Here, we aimed to establish a metabolic signature to identify novel targets in a predictive model of PRAD patients. A total of 133 metabolic differentially ex
Externí odkaz:
https://doaj.org/article/ef4fd314597f47a4b8fd4e488aae787c
Autor:
Jie Wang, Wangrui Liu, Wenhao Xu, Baofeng Yang, Mingzhu Cui, Zhen Li, Hailiang Zhang, Chuntao Jin, Huanzhou Xue, Jiaqiang Zhang
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundAssessing the phenotypic diversity underlying tumor progression requires the identification of variations in the respective molecular interaction in the tumor microenvironment (TME). Despite emerging studies focusing on the association betw
Externí odkaz:
https://doaj.org/article/deb788a8498f4b429a47966b38d78118
Autor:
Shuai Zhao, Cuicui Wei, Haijia Tang, Han Ding, Bing Han, Shuxian Chen, Xiaoling Song, Qiang Gu, Yichi Zhang, Wangrui Liu, Jian Wang
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Background and ObjectiveHepatocellular carcinoma (HCC) is one of the most common cancers worldwide, and the DNA polymerase delta (POLD) family is significantly related to cancer prognosis. This study aimed to explore the significance of the POLD fami
Externí odkaz:
https://doaj.org/article/00386c90fff0454f8beb646c7174ef8d